i
Use of Ebola vaccine : recommendations of the Advisory Committee on Immunization Practices, United States, 2020
-
01/08/2021
-
-
Source: Recommendations and Reports / January 8, 2021 / 70(1);1–12
Details:
-
Journal Article:MMWR. Recommendations and Reports
-
Personal Author:
-
Corporate Authors:Centers for Disease Control and Prevention (U.S.) ; United States Advisory Committee on Immunization Practices. ; National Center for Emerging and Zoonotic Infectious Diseases (U.S.) ; McMaster University. Department of Health Research Methods, Evidence, and Impact. ; University of Arizona College of Public Health. ; ... More +
-
Description:This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the United States The vaccine contains rice-derived recombinant human serum albumin and live attenuated recombinant vesicular stomatitis Virus (VSV) in which the gene encoding the glycoprotein of VSV was replaced with the gene encoding the glycoprotein of Ebola Virus species Zaire ebolaVirus. Persons with a History of severe allergic reaction (e.g., anaphylaxis) to rice protein should not receive Ervebo. This is the first and only vaccine currently licensed by the Food and Drug Administration for the Prevention of Ebola Virus disease (EVD). These guidelines will be updated based on availability of new data or as new vaccines are licensed to protect against EVD.
-
Subjects:
-
Source:
-
Series:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: